Rx for Biotech
By Podcast Host Chris Leidli
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Podcast Host Chris Leidli
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 93
Description
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care.
Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:
• Biotech and pharmaceutical CEOs
• Physician leaders and researchers
• AI and tech leaders building tools to improve healthcare access
• Innovators building the next generation of personalized therapies
About Therapy4me.ai
Therapy4me.ai is a consumer education and care-navigation platform designed to help patients find and connect with specialists at treatment centers offering personalized medicines and advanced therapies.
Learn more: https://www.therapy4me.ai
To learn more about Genoplex, please visit https://www.genoplex.ai
| Episode | Date |
|---|---|
|
Can Stem Cell Therapy Heal Chronic Back Pain? The Future of Regenerative Medicine
|
Jul 23, 2026 |
|
Part 2: What Is Radioligand Therapy? A New Precision Treatment for Cancer Explained
|
Jul 07, 2026 |
|
Part 1: The Radiopharmaceutical Launch Playbook: What Pharma Must Get Right Beyond the Drug
|
Jun 30, 2026 |
|
Why Fertility Care Needs to Change - And How Technology Can Help
|
Jun 16, 2026 |
|
The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
|
May 30, 2026 |
|
What If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained
|
May 19, 2026 |
|
The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
|
May 07, 2026 |
|
How Ossium Health is Changing Stem Cell Therapy and Regenerative Medicine
|
Apr 28, 2026 |
|
How Targeted Chemotherapy and Immunotherapy are Changing Cancer Care
|
Apr 14, 2026 |
|
The Future of Precision Medicine: How Biomarkers Can Guide Your Treatment
|
Mar 24, 2026 |
|
How Novartis is Changing Cancer Treatment and Putting Patients First in Modern Cancer Care
|
Mar 12, 2026 |
|
Fixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases
|
Feb 11, 2026 |
|
How to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist
|
Jan 27, 2026 |
|
A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy
|
Jan 15, 2026 |
|
Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
|
Nov 20, 2025 |
|
How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
|
Nov 11, 2025 |
|
Restoring Breath: Biologic Innovation for the Most Vulenerable Patients
|
Oct 28, 2025 |
|
Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
|
Oct 14, 2025 |
|
The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
|
Sep 09, 2025 |
|
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
|
Aug 21, 2025 |
|
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
|
Aug 05, 2025 |
|
Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
|
Jul 24, 2025 |
|
How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
|
Jun 03, 2025 |
|
Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
|
May 08, 2025 |
|
How AI is Transforming Job Search and Recruiting in Life Sciences and Technology
|
Apr 24, 2025 |
|
From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
|
Mar 24, 2025 |
|
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
|
Mar 02, 2025 |
|
New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc
|
Jan 06, 2025 |
|
From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
|
Dec 18, 2024 |
|
How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
|
Dec 03, 2024 |
|
The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
|
Nov 12, 2024 |
|
How NGGT is Pioneering the Next Wave of Gene Therapies
|
Oct 10, 2024 |
|
Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
|
Sep 18, 2024 |
|
Left Behind: Addressing Health Equity for the Rare Disease Patient Community
|
Sep 09, 2024 |
|
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
|
Sep 05, 2024 |
|
Unlocking AI In Oncology with James Zou, PhD
|
Aug 27, 2024 |
|
Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan
|
Aug 22, 2024 |
|
Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine
|
Aug 14, 2024 |
|
How MedStack helps Health Tech companies with Compliance and Data Privacy
|
Jul 28, 2024 |
|
How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
|
Jul 09, 2024 |
|
ASCO 2024 Recap, ADCs, Cell Therapies and RLTs
|
Jun 13, 2024 |
|
ASGCT 2024 Abstracts Preview
|
Apr 23, 2024 |
|
Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics
|
Mar 28, 2024 |
|
How Ryght is Building a Generative AI Platform for BioPharma
|
Mar 18, 2024 |
|
Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar
|
Mar 14, 2024 |
|
ASGCT Annual Meeting Preview
|
Mar 11, 2024 |
|
2024 Biopharma Investment Outlook with Chris Dokomajilar
|
Feb 12, 2024 |
|
How one Survivor beat the odds against Mucosal Melanoma
|
Jan 11, 2024 |
|
Mark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes
|
Jan 04, 2024 |
|
Episode 2: Future Advances in Cell Therapy Analytics
|
Dec 19, 2023 |
|
Episode 1: Current Advancements in Cell Therapy Analytics
|
Dec 10, 2023 |
|
Health Policy Update: IRA, 340b Drug Pricing and PBMs
|
Oct 11, 2023 |
|
Special Episode: ASGCT Policy Summit Highlights
|
Sep 24, 2023 |
|
The IRA 1-year Anniversary Episode: What Lies Ahead?
|
Sep 21, 2023 |
|
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
|
Sep 19, 2023 |
|
ASGCT Policy Summit Preview
|
Sep 10, 2023 |
|
How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes
|
Sep 07, 2023 |
|
How Medicenna is Developing "Superkines" as Novel Immunotherapies
|
Aug 31, 2023 |
|
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing
|
Jul 13, 2023 |
|
Novel Immunotherapy approaches to engaging the Innate Immune System
|
Jul 06, 2023 |
|
Emerging Therapies for Rare Genetic Mitochondrial Diseases
|
Jun 21, 2023 |
|
Harnessing the Cell Cycle to Treat Cancer and other Serious Diseases
|
Jun 13, 2023 |
|
American Society of Gene and Cell Therapy Meeting Highlights
|
May 30, 2023 |
|
Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD
|
May 09, 2023 |
|
Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron
|
May 02, 2023 |
|
Erandi De Silva, PhD on Building a Gene Therapy Pipeline and Culture
|
Apr 25, 2023 |
|
Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, PhD
|
Apr 18, 2023 |
|
AACR 2023 Preview
|
Apr 11, 2023 |
|
New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD
|
Mar 29, 2023 |
|
FDA AMAT for Regenerative Medicine Therapies Workshop Recap
|
Mar 21, 2023 |
|
Don Davis, PhD, MBA on Challenges in Scaling Life Science Companies
|
Feb 27, 2023 |
|
Applications of AI and Machine Learning in BioPharma and Healthcare
|
Feb 14, 2023 |
|
A Look Ahead to 2023 Biopharma M&A, Venture Financing, Licensing and Partnerships
|
Jan 23, 2023 |
|
Biopharma Products and Companies to Watch in 2023
|
Jan 12, 2023 |
|
American Society of Hematology Highlights
|
Dec 16, 2022 |
|
Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows
|
Dec 07, 2022 |
|
How to Improve Customer Engagement in 2023
|
Nov 21, 2022 |
|
Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah
|
Nov 07, 2022 |
|
Meeting on the Mesa Roundtable Part 2: Applying "A-Cell" Concepts when Developing Cell Therapies
|
Oct 27, 2022 |
|
Meeting on the Mesa Roundtable Part 1: 'A-Cell' Principles of Quality by Design
|
Oct 20, 2022 |
|
IRA Impact on Biopharma Drug Development
|
Oct 07, 2022 |
|
OTAT Townhall Insights for Developers of Gene Therapies
|
Sep 29, 2022 |
|
Insights into the Cell and Gene Therapy Landscape
|
Sep 22, 2022 |
|
Medical Communications after the Pandemic
|
Sep 15, 2022 |
|
Best Practices in Market Access, Trade and Distribution
|
Sep 08, 2022 |
|
Chandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems
|
Jun 02, 2022 |
|
Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
|
May 23, 2022 |
|
CRISPR and Gene Editing for Human Disease
|
Jun 20, 2020 |
|
The Future of Cell and Gene Therapies
|
May 19, 2020 |
|
Regulatory Challenges in Biotech
|
May 01, 2020 |